Treatment of solid tumors following allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 25, Issue 8, 2000, Pages 895-898

  Favre Schmuziger, G ^a   Hofer, S ^a   Passweg, J ^a   Tichelli, A ^a   Hoffmann, T ^a   Speck, B ^a   Herrmann, R ^a   Gratwohl, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bone marrow transplantation; Outcome; Second solid tumor; Treatment

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE; VINDESINE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MALE; OSTEOSARCOMA; OVARY CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOMA; SCHOOL CHILD; SOLID TUMOR; THYROID CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0034076744     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702339     Document Type: Article

References (17)

1. Armitage J. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
2. Schmitz N, Gratwohl A, Goldman JM et al. Guidelines for allogeneic and autologous transplantation in haematological diseases, solid tumors and immune disorders. Bone Marrow Transplant 1996; 17: 471-477.
3. Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639.
4. Tichelli A, Gratwohl A, Uhr M et al. Gesundheitszustand und Spätkomplikationen nach allogener Knochenmarktransplantation. Schweiz Med Wschr 1991; 121: 1473-1481.
5. Shapiro RS, McClain K, Frizzera G et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988; 71: 1234-1243.
6. Socié G, Henry-Amar M, Devergie A et al. Malignant diseases after allogeneic bone marrow transplantation: an updated overview. Nouv Rev Fr Hemtol 1994; 36 (Suppl. 1): 75-77.
7. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. New Engl J Med 1989; 321: 784-789.
8. Kolb HJ, Duell T, Socié G et al. New malignancies in patients surviving more than 5 years after marrow transplantation. Blood 1995; 86 (Suppl. 1): 460a (Abstr.).
9. Papadopoulos EB, Ladanyi M, Emmanuel D et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New Engl J Med 1994; 330: 1185-1191.
10. Deeg HJ, Socié G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833-1844.
11. Speck B, Gratwohl A, Tichelli A, Nissen C. Knochenmark-transplantation. Schweiz Med Wschr 1995; 125: 1515-1532.
12. Socié G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277-279.
13. Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris Analysis of results in 700 patients. Blood 1996; 87: 386-392.
14. Atree SV, Crilley PA, Conroy JF et al. Cancer of the esophagus following allogeneic bone marrow transplantation for acute leukemia. Am J Clin Oncol 1995; 18: 343-347.
15. Socié G, Henry-Amar M, Devergie A et al. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leak Lymphoma 1992; 7: 419-423.
16. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancer after bone marrow transplantation. New Engl J Med 1997, 336, 13: 897-904.
17. Lishner M, Patterson B, Kandel R et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 1990; 65: 473-476.